News

A Scripps Research team has designed a bacterium with two unnatural bases, called X and Y, which could someday help them produce new molecules for medical therapies.

"One can use this new technology to modify a drug molecule at a late stage of synthesis..."

A new study is the first to show precisely how a process in nerve cells called the S-nitrosylation (SNO) reaction may contribute to Parkinson’s disease.

"Uncovering the process by which neutralizing antibodies develop is critical to HIV vaccine design."

Understanding how brains actively erase memories may open new understanding of memory loss and aging, and open the possibility of new treatments for neurodegenerative disease.

Ninety-one Americans die every day from opioid overdoses—deaths caused when opiates like oxycontin, heroin and fentanyl slow and eventually stop a person’s breathing.

Scripps Research and PATH collaboration provides blueprint for design of a next-generation vaccine.

Researchers report the discovery that a protein called “Runx3” programs killer T cells to establish residence in tumors and infection sites.

“This drug candidate is poised to go into clinical trials, and we think it might be effective against multiple forms of autism."

"The success of ozanimod shows that academia and the NIH can make transforming discoveries that benefit patients and those that care for them."

Scientists at Scripps Research have discovered a compound that in laboratory tests irreversibly stops the growth of certain aggressive, treatment-resistant tumor cells.

"It’s certainly plausible that such compounds were present on the early Earth and played a role in the emergence of the complex molecules of life."

Bacterial growth on medical devices—such as artificial hip implants, knee implants and catheters—are a major threat to patient health.

The new study shows exactly why egg-based manufacturing is a problem for the H3N2 influenza subtype.

MyGeneRank app allows individuals with genetic data from 23andMe to obtain an estimated genetic risk score for coronary artery disease.

“Our new ADCs are built something like a double-decker bus..."

Scientists have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells.

Election to the Academy is considered one of the highest honors in the fields of health and medicine.

"Because of our aging population, these kinds of therapeutics are in great demand..."

A fascinating new look at fruit fly behavior.

Chemists at Scripps Research have demonstrated that they can repurpose DNA to create new substances with possible medical applications.

The center includes scientists from both the California and Florida campuses of Scripps Research.

Informatics experts at Scripps Research have been awarded close to $3 million as part of a five-year cooperative agreement to launch the National Center for Data to Health (CD2H).

"This new approach shows promise for identifying previously unrecognized ‘druggable’ targets in cancers that lack effective treatments."